Published on February 11, 2026 by Caroline Bernard
Study report Intellectual property in the field of bioproduction and biomedicines
The French intellectual property landscape is characterised by its stability and the predominance of its academic fabric.
France ranks fourth in Europe in terms of the number of active patent families
- The portfolio is diversified with no marked specialisation.
- Portfolio growth is in line with the European average.
- It is divided 50-50 between academics and private companies.
- It is concentrated with INSERM, CNRS, Université Paris Cité and Sanofi in the top 10 applicants.
Click to access the full report
